Literature DB >> 11120925

Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype.

H S Lee1, P Brown, L Cervenáková, R M Garruto, M P Alpers, D C Gajdusek, L G Goldfarb.   

Abstract

Kuru reached epidemic proportions by the mid-twentieth century among the Fore people of New Guinea and disappeared after the abolition of cannibalistic rituals. To determine susceptibility to kuru and its role in the spread and elimination of the epidemic, we analyzed the PRNP gene coding sequences in 5 kuru patients; no germline mutations were found. Analysis of the PRNP 129 methionine (M)/valine (V) polymorphism in 80 patients and 95 unaffected controls demonstrated that the kuru epidemic preferentially affected individuals with the M/M genotype. A higher representation of M/M carriers was observed among the affected young Fore males entering the age of risk, whereas a lower frequency of M/M homozygotes was found among the survivors. M/V and V/V genotypes predisposed to a lower risk of disease development and longer incubation times. These findings are relevant to the current outbreak of variant Creutzfeldt-Jakob disease (vCJD) in the United Kingdom, because all vCJD patients tested thus far have been M/M carriers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120925     DOI: 10.1086/317935

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Genotype frequencies at codon 129 of the prion protein gene in Brazil: Implications in susceptibility to variant Creutzfeldt-Jakob disease compared to European and Asian populations.

Authors:  Erich Vinicius de Paula; Marcelo Addas-Carvalho; Devanira Souza Paixao Costa; Sara Terezinha Olalla Saad; Simone Cristina Olenscki Gilli
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility.

Authors:  Paul Clarke; Azra C Ghani
Journal:  J R Soc Interface       Date:  2005-03-22       Impact factor: 4.118

Review 4.  The prion strain phenomenon: molecular basis and unprecedented features.

Authors:  Rodrigo Morales; Karim Abid; Claudio Soto
Journal:  Biochim Biophys Acta       Date:  2006-12-15

5.  Epidemiological mechanisms of genetic resistance to kuru.

Authors:  Katherine E Atkins; Jeffrey P Townsend; Jan Medlock; Alison P Galvani
Journal:  J R Soc Interface       Date:  2013-06-05       Impact factor: 4.118

6.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

7.  Intraspecies prion transmission results in selection of sheep scrapie strains.

Authors:  Takashi Yokoyama; Kentaro Masujin; Mary Jo Schmerr; Yujing Shu; Hiroyuki Okada; Yoshifumi Iwamaru; Morikazu Imamura; Yuichi Matsuura; Yuichi Murayama; Shirou Mohri
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

8.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

Review 9.  Review. The neuropathology of kuru and variant Creutzfeldt-Jakob disease.

Authors:  Catriona A McLean
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

10.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.